Figure1.jpg (Figure1)
Chemical structure of montelukast sodium displayed as a molecular diagram showing its atomic arrangement and bonding.*
Montelukast Tablet, Film Coated
Product Images NDC 50090-6109
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Montelukast (NDC 50090-6109). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure2.jpg (Figure2)
A line graph showing mean percent change from baseline over weeks of treatment comparing Montelukast Sodium and placebo. The x-axis represents weeks of treatment up to 15 weeks including a washout period, while the y-axis shows mean percent change. Montelukast Sodium demonstrates a higher percent change compared to placebo across the treatment period.*
Camberlogo1 (Camberlogo1)
Camberlogo2 (Camberlogo2)
Label Image (Lbl500906109)
MONTELUKAST 10 mg film coated tablets packaging label from A-S Medication Solutions. The label indicates each tablet contains 10 mg Montelukast Sodium, with storage instructions to keep at 68 to 77 degrees Fahrenheit, protected from moisture and light. The package contains 90 tablets and includes dosage barcode and NDC 50090-6109-0.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
